{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:29:01Z","timestamp":1792016941462,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A_149925"],"award-info":[{"award-number":["31003A_149925"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss Cancer League","award":["KFS-2993-08-2012"],"award-info":[{"award-number":["KFS-2993-08-2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jconrel.2017.02.031","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T22:38:04Z","timestamp":1488321484000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination"],"prefix":"10.1016","volume":"251","author":[{"given":"Mona O.","family":"Mohsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane C.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cabral-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana MS","family":"Leoratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens V.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.02.031_bb0005","series-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2007"},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jconrel.2017.02.031_bb0015","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/CJI.0b013e3181f1d614","article-title":"Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients","volume":"33","author":"Speiser","year":"2010","journal-title":"J. Immunother."},{"issue":"3","key":"10.1016\/j.jconrel.2017.02.031_bb0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/eji.200425755","article-title":"Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles","volume":"35","author":"Schwarz","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2017.02.031_bb0025","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.172.3.1777","article-title":"Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects","volume":"172","author":"Storni","year":"2004","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2017.02.031_bb0030","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2017.02.031_bb0035","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2017.02.031_bb0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI23373","article-title":"Rapid and strong human CD8(+) T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909","volume":"115","author":"Speiser","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"6522","key":"10.1016\/j.jconrel.2017.02.031_bb0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jconrel.2017.02.031_bb0050","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of Toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"6813","key":"10.1016\/j.jconrel.2017.02.031_bb0060","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jconrel.2017.02.031_bb0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2017.02.031_bb0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2017.02.031_bb0075","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.jconrel.2017.02.031_bb0085","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2567.2007.02530.x","article-title":"Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals","volume":"120","author":"Martinson","year":"2007","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.jconrel.2017.02.031_bb0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.6.5.747","article-title":"Immunostimulatory DNA as a vaccine adjuvant","volume":"6","author":"Higgins","year":"2007","journal-title":"Expert Rev. Vaccines"},{"issue":"8","key":"10.1016\/j.jconrel.2017.02.031_bb0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djs033","article-title":"Therapeutic cancer vaccines: current status and moving forward","volume":"104","author":"Schlom","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0105","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.162.4.2368","article-title":"Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis","volume":"162","author":"Sparwasser","year":"1999","journal-title":"J. Immunol."},{"issue":"5124","key":"10.1016\/j.jconrel.2017.02.031_bb0110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.8351515","article-title":"Antisense oligonucleotides as therapeutic agents - is the bullet really magical","volume":"261","author":"Stein","year":"1993","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jconrel.2017.02.031_bb0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/dmd.113.055434","article-title":"Biodistribution and metabolism studies of lipid nanoparticle-formulated internally [3H]-labeled siRNA in mice","volume":"42","author":"Christensen","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.jconrel.2017.02.031_bb0120","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/eji.201142361","article-title":"Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients","volume":"42","author":"Goldinger","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.031_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-422X-9-52","article-title":"Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity","volume":"9","author":"Zhao","year":"2012","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/157016210791208659","article-title":"Virus-like particles as particulate vaccines","volume":"8","author":"Buonaguro","year":"2010","journal-title":"Curr. HIV Res."},{"issue":"5","key":"10.1016\/j.jconrel.2017.02.031_bb0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol. Chem."},{"issue":"11","key":"10.1016\/j.jconrel.2017.02.031_bb0140","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1128\/JVI.77.11.6466-6473.2003","article-title":"Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding","volume":"77","author":"Conway","year":"2003","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.jconrel.2017.02.031_bb0145","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1182\/blood-2008-10-185421","article-title":"BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation","volume":"113","author":"Eckl-Dorna","year":"2009","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.jconrel.2017.02.031_bb0150","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jconrel.2017.02.031_bb0155","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.4049\/jimmunol.168.6.2880","article-title":"Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles","volume":"168","author":"Storni","year":"2002","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.jconrel.2017.02.031_bb0160","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.R700009200","article-title":"Toll-like receptors and Type I interferons","volume":"282","author":"Uematsu","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jconrel.2017.02.031_bb0165","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.4049\/jimmunol.172.10.6129","article-title":"Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison","volume":"172","author":"Storni","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2017.02.031_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/clin.1993.1129","article-title":"Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA","volume":"68","author":"Gilkeson","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jconrel.2017.02.031_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1990.tb00815.x","article-title":"Theoretical and experimental approaches to generalized autoimmunity","volume":"118","author":"Steinberg","year":"1990","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2017.02.031_bb0180","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2222.2008.03191.x","article-title":"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I\/IIa clinical trial","volume":"39","author":"Senti","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.jconrel.2017.02.031_bb0185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0092-8674(94)90142-2","article-title":"Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy","volume":"77","author":"Crowther","year":"1994","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2017.02.031_bb0190","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2017.02.031_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.0901540","article-title":"Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles","volume":"184","author":"Keller","year":"2010","journal-title":"J. Immunol."},{"issue":"5808","key":"10.1016\/j.jconrel.2017.02.031_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jconrel.2017.02.031_bb0205","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.4049\/jimmunol.0804004","article-title":"Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses","volume":"183","author":"Bessa","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2017.02.031_bb0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-5793(00)02061-5","article-title":"Mutilation of RNA phage Qbeta virus-like particles: from icosahedrons to rods","volume":"482","author":"Cielens","year":"2000","journal-title":"FEBS Lett."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2017.02.031_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000150469","article-title":"RNA phage Q beta coat protein as a carrier for foreign epitopes","volume":"39","author":"Kozlovska","year":"1996","journal-title":"Intervirology"},{"issue":"6970","key":"10.1016\/j.jconrel.2017.02.031_bb0220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nature02238","article-title":"T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases","volume":"427","author":"Mempel","year":"2004","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jconrel.2017.02.031_bb0225","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2009-11-254334","article-title":"Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing","volume":"116","author":"Boscacci","year":"2010","journal-title":"Blood"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:32:20Z","timestamp":1759159940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":45,"alternative-id":["S0168365917300895"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}